Arch Ophthalmol Chic
-
Arch Ophthalmol Chic · Jan 1986
Randomized Controlled Trial Clinical TrialArgon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group.
The Branch Vein Occlusion Study is a multicenter, randomized, controlled clinical trial designed to answer several questions regarding the management of complications of branch vein occlusion. This report addresses the questions, "Can peripheral scatter argon laser photocoagulation prevent the development of neovascularization?" and "Can peripheral scatter argon laser photocoagulation prevent vitreous hemorrhage?" To answer the first question, 319 eyes were assigned randomly to either a treated or an untreated control group. Comparing treated patients with control patients (average follow-up time, 3.7 years), the development of neovascularization was significantly less in treated eyes (P = .009, log rank test). ⋯ Comparing treated patients with control patients (average follow-up time, 2.8 years), the development of vitreous hemorrhage was significantly less in treated eyes (P = .005, log rank test). Although the Branch Vein Occlusion Study was not designed to determine whether peripheral scatter treatment should be applied before rather than after the development of neovascularization, data accumulated in this study suggest that peripheral scatter treatment should be applied after the development of neovascularization rather than before the development of neovascularization. Because the occurrence of vitreous hemorrhage was lessened by peripheral scatter argon laser photocoagulation, we recommend laser photocoagulation for patients with branch vein occlusion who have developed neovascularization and who meet the eligibility criteria of this study.
-
Arch Ophthalmol Chic · Jun 1985
Retrobulbar anesthesia in strabismus surgery. II. Use of a short-acting anesthetic agent.
Forty-two patients underwent strabismus surgery with a retrobulbar injection of 3% chloroprocaine hydrochloride. In the 18 patients who were followed up in the immediate postoperative period, the average duration of action of 3% chloroprocaine was found to be 2.13 hours. In addition to the advantages of local anesthesia, this short-acting anesthetic permits earlier modifications of adjustable sutures and the earlier discharge of patients on the same day as surgery.
-
Arch Ophthalmol Chic · Mar 1985
Intraoperative adjustment of eye muscle surgery. Correction based on eye position during general anesthesia.
During general anesthesia, the eye position of patients with strabismus, measured by Krimsky's test at 1 m, 30 minutes after induction, has a linear correlation with the eye position measured clinically preoperatively. A similar study was performed on 77 patients; however, Hirschberg's test was used for simplicity and was performed as soon as the patient was in a surgical plane of anesthesia. We confirmed that there was a linear correlation. ⋯ We did approximately 1 mm more or less surgery than we had planned on each eye muscle. This significantly improved the final results in anomalous cases. Patients with anomalous tests who did not have such adjustments had significantly poorer results.
-
Arch Ophthalmol Chic · May 1984
Randomized Controlled Trial Clinical TrialChemical preparation of the eye in ophthalmic surgery. III. Effect of povidone-iodine on the conjunctiva.
A half-strength povidone-iodine (Betadine) solution was used topically as part of the preoperative chemical preparation of the eye. Aerobic and anaerobic bacterial cultures of the conjunctiva were taken before and after the chemical preparation in 30 consecutive patients; the second eye served as a control. ⋯ In the povidone-iodine-treated eyes, the numbers of colonies decreased 91% and the number of species decreased 50% (statistically significant). We therefore recommend that a half-strength povidone-iodine solution be used as part of the chemical preparation of the eye for surgery.